Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Average annual age-adjusted cancer incidence rates were calculated for each poverty area group in New Jersey. Included in the report are the average annual age-adjusted incidence rates per 100,000 population for all types of cancer combined and 16 cancers that are the most common types among men and/or women, or among the leading causes of cancer death. The 16 specific cancer types are female breast cancer, cervical cancer, colorectal cancer, endometrial cancer, esophageal cancer, liver cancer, lung and bronchus cancer, melanoma of the skin, non-Hodgkin lymphoma, oral (oral cavity and pharynx) cancer, ovarian cancer, pancreas cancer, prostate. | Evidence Report Technology Assessment_ Number 160 Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes Prepared for Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville MD 20850 www.ahrq.gov Contract No. 290-02-0018 Prepared by The Johns Hopkins University Evidence-based Practice Center Baltimore MD Investigators Luigi Marchionni M.D. Ph.D. Renee F. Wilson M.Sc. Spyridon S. Marinopoulos M.D. M.B.A. Antonio C. Wolff M.D. Giovanni Parmigiani M.D. Eric B. Bass M.D. M.P.H. Steven N. Goodman M.D. M.H.S. Ph.D. AHRQ Publication No. 08-E002 January 2008 This report is based on research conducted by the Johns Hopkins University Evidence-based Practice Center EPC under contract to the Agency for Healthcare Research and Quality AHRQ Rockville MD Contract No. 290-02-0018 . The findings and conclusions in this document are those of the author s who are responsible for its content and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The information in this report is intended to help clinicians employers policymakers and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment. This report may be used in whole or in part as the basis for the development of clinical practice guidelines and other quality enhancement tools or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied. This document is in the public domain and may be used and reprinted without permission except those copyrighted materials noted for which further reproduction is prohibited without the specific permission of copyright holders. Suggested .
